Jasper Therapeutics, Inc. (JSPR) Reports In-Line Q2 EPS

Jasper Therapeutics, Inc. (NASDAQ: JSPR) reported Q2 EPS of ($0.15), in-line with the analyst estimate of ($0.15).

For earnings history and earnings-related data on Jasper Therapeutics, Inc. (JSPR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c